Heterotopic ossification in the setting of neuromuscular blockade.

OBJECTIVE Heterotopic ossification (HO) is a disorder characterized by the formation of new bone in tissue that does not ossify under normal conditions. We report a series of 6 cases in which HO occurred in the setting of adult respiratory distress syndrome (ARDS). We wished to show that HO can occur after neuromuscular blockade and that these cases might provide additional evidence that HO is influenced by neural mechanisms. METHODS Cases of HO were selected from the consultation services at the Massachusetts General Hospital and the Brigham and Women's Hospital. Affected patients all had ARDS and had been treated with a neuromuscular blocking agent. Patients with a history of stroke, burn, head trauma, spinal cord injury, or joint replacement were excluded from this study. RESULTS Heterotopic bone appeared around large joints in a pattern identical to that seen in patients with paralysis, traumatic brain injury, severe burns, or trauma. New bone formation was self-limited over a period of 1-2 years. Alkaline phosphatase and technetium bone scan were sensitive ways of detecting early disease and monitoring disease activity. Medical therapies had limited benefit. Surgical excision of mature new bone appeared to be the only definitive therapy. CONCLUSION Neuromuscular blockade in the setting of ARDS appears to be an important risk factor for the development of HO. The similarity of these cases of HO occurring in patients with brain or spinal cord injury raises the possibility that neural mechanisms may be important in the pathogenesis of this disease. Whether the type of neuromuscular blocking agent and the duration of use are important determinants of disease severity remains to be determined.

[1]  R. Derynck,et al.  Toward a molecular understanding of skeletal development , 1995, Cell.

[2]  V. Rosen,et al.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713] , 1994, The Journal of cell biology.

[3]  V. Rosen,et al.  Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  N. Clements,et al.  Heterotopic ossification complicating critical illness. , 1993, Chest.

[5]  R. Sauer,et al.  Prophylactic radiation therapy for prevention of heterotopic ossification after hip arthroplasty: results in 141 high-risk hips. , 1993, Radiology.

[6]  C. DeFlitch,et al.  Postoperative hip irradiation in prevention of heterotopic ossification: causes of treatment failure. , 1993, Radiology.

[7]  W. Maloney,et al.  Prophylaxis for heterotopic bone formation after total hip arthroplasty using low-dose radiation in high-risk patients. , 1992, Clinical orthopaedics and related research.

[8]  R. Buschbacher,et al.  WARFARIN IN PREVENTION OF HETEROTOPIC OSSIFICATION , 1992, American journal of physical medicine & rehabilitation.

[9]  A. Reddi,et al.  Growth and morphogenetic factors in bone induction: role of osteogenin and related bone morphogenetic proteins in craniofacial and periodontal bone repair. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[10]  R. Buschbacher,et al.  NONINFLAMMATORY KNEE JOINT EFFUSIONS IN SPINAL CORD‐INJURED AND OTHER PARALYZED PATIENTS Four Case Studies , 1991, American journal of physical medicine & rehabilitation.

[11]  S. L. Stover,et al.  Experience with surgical resection of heterotopic bone in spinal cord injury patients. , 1991, Clinical orthopaedics and related research.

[12]  P. Kjaersgaard-Andersen,et al.  Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification. , 1991, Clinical orthopaedics and related research.

[13]  D. Garland A clinical perspective on common forms of acquired heterotopic ossification. , 1991, Clinical orthopaedics and related research.

[14]  A. Ekelund,et al.  Experimental induction of heterotopic bone. , 1991, Clinical orthopaedics and related research.

[15]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  D. Garland,et al.  Resection of heterotopic ossification in patients with spinal cord injuries. , 1989, Clinical orthopaedics and related research.

[18]  M. Brooke,et al.  SPECIAL REVIEW NEUROGENIC HETEROTOPIC OSSIFICATION , 1988 .

[19]  N. W. Pedersen,et al.  Serum Alkaline Phosphatase as an Indicator of Heterotopic Bone Formation Following Total Hip Arthroplasty , 1988, Clinical orthopaedics and related research.

[20]  M. Brooke,et al.  Neurogenic heterotopic ossification. , 1987, American journal of physical medicine.

[21]  F. C. Bauer,et al.  High doses of the diphosphonate EHDP for the prevention of heterotopic ossification. An experimental and clinical study. , 1987, Scandinavian journal of rheumatology.

[22]  T. Rudd,et al.  Heterotopic bone formation: clinical, laboratory, and imaging correlation. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  T. Gennarelli,et al.  Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. , 1983, Archives of physical medicine and rehabilitation.

[24]  D. Garland,et al.  Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. , 1983, Clinical orthopaedics and related research.

[25]  M. Urist,et al.  Bone cell differentiation and growth factors. , 1983, Science.

[26]  G. Finerman,et al.  Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP. , 1981, Metabolic bone disease & related research.

[27]  J. Michelsson,et al.  Myositis ossificans following forcible manipulation of the leg. A rabbit model for the study of heterotopic bone formation. , 1980, The Journal of bone and joint surgery. American volume.

[28]  H. Schumacher,et al.  Heterotopic ossification mimicking acute arthritis after neurologic catastrophes. , 1977, Archives of internal medicine.

[29]  A. Rossier,et al.  Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. , 1977, Radiology.

[30]  S. L. Stover,et al.  Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. , 1976, The Journal of bone and joint surgery. American volume.

[31]  K. Buring On the origin of cells in heterotopic bone formation. , 1975, Clinical orthopaedics and related research.

[32]  K. Hisada,et al.  Demonstration of myositis ossificans by 99mTc pyrophosphate bone scanning. , 1974, Radiology.

[33]  J. Nicholas,et al.  Elevation of the serum alkaline phosphatase coincident with ectopic-bone formation in paraplegic patients. , 1970, The Journal of bone and joint surgery. American volume.

[34]  J. Brailsford,et al.  The Radiology of Bones and Joints , 1934, The Indian Medical Gazette.